<em>Campylobacter jejuni</em> promotes colorectal tumorigenesis through the action of cytolethal distending toxin - INRAE - Institut national de recherche pour l’agriculture, l’alimentation et l’environnement
Journal Articles Gut Year : 2019

Campylobacter jejuni promotes colorectal tumorigenesis through the action of cytolethal distending toxin

Abstract

Objective Campylobacter jejuni produces a genotoxin, cytolethal distending toxin (CDT), which has DNAse activity and causes DNA double-strand breaks. Although C. jejuni infection has been shown to promote intestinal inflammation, the impact of this bacterium on carcinogenesis has never been examined. Design Germ-free (GF) Apc(Min/+) mice, fed with 1% dextran sulfate sodium, were used to test tumorigenesis potential of CDT-producing C. jejuni. Cells and enteroids were exposed to bacterial lysates to determine DNA damage capacity via gamma H2AX immunofluorescence, comet assay and cell cycle assay. To examine the interplay of CDT-producing C. jejuni, gut microbiome and host in tumorigenesis, colonic RNA-sequencing and faecal 16S rDNA sequencing were performed. Rapamycin was administrated to investigate the prevention of CDT-producing C. jejuni-induced tumorigenesis. Results GF Apc(Min/+) mice colonised with human clinical isolate C. jejuni81-176 developed significantly more and larger tumours when compared with uninfected mice. C. jejuni with a mutated cdtB subunit, mutcdtB, attenuated C. jejuni-induced tumorigenesis in vivo and decreased DNA damage response in cells and enteroids. C. jejuni infection induced expression of hundreds of colonic genes, with 22 genes dependent on the presence of cdtB. The C. jejuni-infected group had a significantly different microbial gene expression profile compared with the mutcdtB group as shown by metatranscriptomic data, and different microbial communities as measured by 16S rDNA sequencing. Finally, rapamycin could diminish the tumorigenic capability of C. jejuni. Conclusion Human clinical isolate C. jejuni 81-176 promotes colorectal cancer and induces changes in microbial composition and transcriptomic responses, a process dependent on CDT production.
Fichier principal
Vignette du fichier
he-gut_2018_1.pdf (6.48 Mo) Télécharger le fichier
Origin Publisher files allowed on an open archive
Loading...

Dates and versions

hal-02627995 , version 1 (26-05-2020)

Licence

Identifiers

Cite

Zhen He, Raad Z. Gharaibeh, Rachel C. Newsome, Jllian L. Pope, Michael W. Dougherty, et al.. Campylobacter jejuni promotes colorectal tumorigenesis through the action of cytolethal distending toxin. Gut, 2019, 68 (2), pp.289-300. ⟨10.1136/gutjnl-2018-317200⟩. ⟨hal-02627995⟩
35 View
67 Download

Altmetric

Share

More